SCHEMBL670637

SCHEMBL670637

O=[N+]([O-])c1ccc(C=Cc2ccc([N+](=O)[O-])cc2S(=O)(=O)O)c(S(=O)(=O)O)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAD51 Q06609 1/20 0.56
▸ NT5E P21589 2/20 0.49
▸ ALDH1A1 P00352 4/20 0.48
▸ TSHR P16473 2/20 0.48
▸ CYP2C19 P33261 1/20 0.48
▸ RAD1 O60671 1/20 0.46
▸ P2RY6 Q15077 1/20 0.46
▸ ERN1 O75460 1/20 0.45
▸ PDE2A O00408 1/20 0.44
▸ PDE5A O76074 1/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ ALOX15 P16050 1/20 0.44
▸ NFKB1 P19838 1/20 0.44
▸ APEX1 P27695 1/20 0.44
▸ PDE4A P27815 1/20 0.44
▸ BLM P54132 1/20 0.44
▸ PDE1B Q01064 1/20 0.44
▸ PMP22 Q01453 1/20 0.44
▸ PDE4B Q07343 1/20 0.44
▸ PDE4D Q08499 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL455776 1.00 RAD51 (0.56) RAD51NT5EALDH1A1TSHRCYP2C19
SCHEMBL455775 1.00 RAD51 (0.56) RAD51NT5EALDH1A1TSHRCYP2C19
SCHEMBL29356717 1.00 RAD51 (0.56) RAD51NT5EALDH1A1TSHRCYP2C19
SCHEMBL6815520 0.98 RAD51 (0.55) RAD51NT5EALDH1A1TSHRCYP2C19
SCHEMBL7744489 0.98 RAD51 (0.55) RAD51NT5EALDH1A1TSHRCYP2C19
SCHEMBL8653989 0.98 RAD51 (0.55) RAD51NT5EALDH1A1TSHRCYP2C19
SCHEMBL10633178 0.98 RAD51 (0.55) RAD51NT5EALDH1A1TSHRCYP2C19
SCHEMBL9818822 0.98 RAD51 (0.58) RAD51NT5EALDH1A1TSHRCYP2C19
SCHEMBL6815530 0.98 RAD51 (0.55) RAD51NT5EALDH1A1TSHRCYP2C19
SCHEMBL7744491 0.98 RAD51 (0.55) RAD51NT5EALDH1A1TSHRCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030022267-A1 Method for determining physiological effects of hemoglobin NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2003-01-30 — — US claimed
EP-1204870-A2 METHOD FOR DETERMINING PHYSIOLOGICAL EFFECTS OF HEMOGLOBIN Duke University (US) 2002-05-15 — — EP claimed
WO-2001009616-A2 METHOD FOR DETERMINING PHYSIOLOGICAL EFFECTS OF HEMOGLOBIN DUKE UNIVERSITY (US) 2001-02-08 — — WO claimed
JP-61282355-A — — None — — JP disclosed
CN-118954805-A DSD acid oxidation wastewater treatment method and application thereof 河北深茂新材料科技有限公司 2024-11-15 — — CN disclosed
CN-113620863-B Piperazine and piperidine derivatives, their synthesis and use 内盖夫国家生物技术研究所 2024-04-05 — — CN disclosed
CN-114011430-B Catalyst for synthesizing DSD acid and preparation method and application thereof 山西晋光化工有限公司 2024-04-02 — — CN disclosed
CN-117362204-A Acid precipitation process for improving DSD acid content 衡水百纳化学有限公司 2024-01-09 — — CN disclosed
CN-116173573-B Filter press for DSD acid production and production process 衡水百纳化学有限公司 2023-08-01 — — CN disclosed
CN-116159490-B Injection device for DSD acid production and production process 衡水百纳化学有限公司 2023-07-07 — — CN disclosed
CN-116173573-A Filter press for DSD acid production and production process 衡水百纳化学有限公司 2023-05-30 — — CN disclosed
US-20090232909-A1 Method for determining physiological effects of hemoglobin MONTANA STATE UNIVERSITY - BOZEMAN 2009-09-17 — — US disclosed
EP-1992495-A1 METHOD FOR IMAGE FORMATION, APPARATUS FOR IMAGE FORMATION, AND APPARATUS FOR INK JET RECORDING Canon Kabushiki Kaisha (JP) 2008-11-19 — — EP disclosed
US-20070242100-A1 IMAGE FORMING METHOD, IMAGE FORMING APPARATUS, AND INK JET RECORDING APPARATUS CANON KABUSHIKI KAISHA (JP) 2007-10-18 — — US disclosed
US-20040002079-A1 Same protein as the lithium- sodium counterttransporter, and is suitable for diagnostic assays for mental illnesses susceptible to lithium therapy, including manic depression GUNN ROBERT B (US) 2004-01-01 — — US disclosed
US-20030022267-A1 Method for determining physiological effects of hemoglobin NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2003-01-30 — — US disclosed
EP-1204870-A2 METHOD FOR DETERMINING PHYSIOLOGICAL EFFECTS OF HEMOGLOBIN Duke University (US) 2002-05-15 — — EP disclosed
WO-2001009616-A2 METHOD FOR DETERMINING PHYSIOLOGICAL EFFECTS OF HEMOGLOBIN DUKE UNIVERSITY (US) 2001-02-08 — — WO disclosed
WO-1998038203-A1 SODIUM-PHOSPHATE COTRANSPORTER IN LITHIUM THERAPY FOR THE TREATMENT OF MENTAL ILLNESS EMORY UNIVERSITY (US) 1998-09-03 — — WO disclosed
JP-S61282355-A MANUFACTURE OF 4,4'-DINITROSTILBENE-2,2'-DISULFONATE BAYER AG 1986-12-12 — — JP disclosed
Send feedback